An interventional study of Glycerin suppositories in Infant, Very Low Birth Weight, sponsored by King Faisal Specialist Hospital & Research Center. Terminated at 3 sites in Saudi Arabia. Open to participants aged Up to 1 Month, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.
Sponsored by King Faisal Specialist Hospital & Research Center · Not applicable, Interventional, and Prevention
To evaluate the efficacy of prophylactic glycerin suppositories will accelerate the elimination of meconium from the large intestine and thus reduce the incidence of feeding intolerance in very low birth weight (VLBW) infants
1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.
This study's enrollment of 220 is above the median of 64 across 947 interventional studies indexed under Body Weight.
Browse Body Weight studies →King Faisal Specialist Hospital & Research Center is the lead sponsor of 98 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Intervention group will receive the glycerin suppository
Drug: Glycerin suppositories
Normal care
days to achieve full tolerated feeding (breast milk or formula) by NGT or by mouth (140cc/kg/day)
Time frame: 2years
Incidence of feeding intolerance
which is defined by the presence of GRVs \> 50 % of the previous feed for two consecutive feeds in addition to two of the following: I. Abdominal distention \> 1 cm in 12 hour. II. Abdominal tenderness. III. Vomiting. IV. Bile stained aspirate.
Time frame: 2years
Incidence of necrotizing enterocolitis (NEC)
Time frame: 2years
This study is terminated, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King Faisal Specialist Hospital & Research Center